A. Rozman (Golnik, Slovenia), T. Strand (Oslo, Norway), N. Dickgreber (Sarstedt, Germany)
Is an EGFR mutation associated with lower glucose metabolism in the FDG-PET?
G. Förster, J. Kollmeier, M. Raible, T. Köcer, S. Griff, D. Kaiser, T. Bauer (Berlin, Germany)
|  |
An analysis of EGFR expression and tumour imaging in non-small cell carcinomas of lung
V. Thanasekaraan, P. Duvuru, S. Rao, S. Mohamed, S. J. Sundar (Chennai, India)
| |
Integrated 18F – FDG PET dynamic contrast enhanced CT to phenotype non-small cell lung cancer
T. Win, M. Shastry, K. Miles, S. Janes, R. Endozo, M. Hill, P. Ell, A. Groves (Stevenage, London, Brighton, United Kingdom)
|  |
FDG-PET SUVmax is an independent prognostic indicator in patients with non-small cell lung cancer
L. J. Smith, N. Navani, P. Bassett, I. Kayani, A. Groves, S. Janes (London, United Kingdom)
| |
Late-breaking abstract: Is primary tumour standardized uptake value (SUV) an independent prognostic factor for non small cell lung cancer (NSCLC)? A meta-analysis based on individual data
M. Paesmans, C. Y. O. Wong, E. F. Patz, R. Komaki, S. Eschmann, R. Govindan, J. Vansteenkiste, A. P. Meert, W. de Jong, K. Higashi, G. Borst, A. Van Baardwijk, L. Ameye, J. J. Lafitte, T. Berghmans, C. Garcia, P. Flamen, R. Rami Porta, J. P. Sculier (Brussels, Leuven, Belgium; Royal Oak, Durham, Houston, St-Louis, United States Of America; Tubingen, Germany; Groningen, Amsterdam, Maastricht, Netherlands; Ishikawa, Japan; Lille, France; Barcelona, Spain)
| |
Is our preoperative TNM staging reliable?
M. Inchausti, L. Garcia, M. Alfonso, R. Diez, A. Urrutia, A. Sagarna, E. Perez, U. Jimenez, P. Ansola (Barakaldo, Spain)
| |
Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC)
L. M. PariEspinoza, D. Huertas Almela, S. Padrones Sanchez, S. Aso González, A. Rosell Gratacós, J. I. Martínez Ballarín, J. Dorca Sargatal, N. González Calzada (Barcelona, Spain)
| |
Assessment of physical functioning in surgical candidates with non-small cell lung cancer: Preliminary comparison of performance status to symptom-limited cardiopulmonary exercise testing
M. A. Roman, N. D. Eves, L. W. Jones (Calgary, Kelowna, Canada; Durham, United States Of America)
| |
Comparison of predictive respiratory function parameters of lung cancer patients having COPD diagnosis with postoperative values and relation with mortality and morbidity
S. Altun, M. Kahraman, D. Kanmaz, E. Yentürk, F. Atabey, C. Kocatürk, E. Tuncay, M. A. Bedirhan, Y. Toraman (Trabzon, Istanbul, Turkey)
| |
Effect of adjuvant chemotherapy on lung function in early stage NSCLC
M. Kreuter, J. Vansteenkiste, I. Zuna, F. Herth, J. Fischer, N. Reinmuth, F. Griesinger, M. Thomas (Heidelberg, Wiesbaden, Loewenstein, Oldenburg, Germany; Leuven, Belgium)
| |
Radiofrequency ablation of lung neoplasms in patients being no candidates for surgery. The impact of the intervention on the pulmonary function
T. Schneider, M. Puderbach, A. Bischof, J. Kunz, H. Dienemann, H. Hoffmann, F. J. F. Herth, C. P. Heussel (Heidelberg, Germany)
| |
Is radiologic evidence of interstitial infiltrate enough to predict FEV1 and DLCO disparity in lung cancer patients?
F. Fernandes, G. Prado, J. Puka, S. João Marcos, A. Albuquerque, M. Araujo, P. Chaves Sampaio, M. Suesada, T. Takagaki (Sao Paulo, Brazil)
| |
Lung function in lung cancer – Room for improvement?
M. Wing, D. Powrie (Southend on Sea, United Kingdom)
| |
Lung cancer size and thoracic lymph nodes metastatic involvement: A correlation
V. Kosjerina Ostric, Z. Kosjerina, G. Djenadic (Sremska Kamenica, Sabac, Republic Of Serbia)
| |
FNA of palpable supraclavicular lymph nodes in lung cancer: Comparison between palpation and ultrasound
D. Spyratos, D. Chloros, A. Mandrali, G. Spyropoulos, C. Gioka, L. Sichletidis (Thessaloniki, Greece)
| |
Is mediastinoscopy necessary in patients with negative EBUS-TBNA – A challenge to the ESTS Guidelines for staging of lung cancer
M. Krasnik, P. Vilmann, F. Herth (Copenhagen, Hellerup, Denmark; Heidelberg, Germany)
| |
CT guided biopsy: Predictors of outcome and complication rate
R. Sarkar, A. Baluwala, J. Jamieson-Young, A. Wight, E. Partridge, M. Babores (Macclesfield, United Kingdom)
| |
The frequency and significance of radiologically detected indeterminate pulmonary nodules in patients with colorectal cancer
Y. Varol, U. Varol, B. Karaca, R. Uslu, R. Savas (Izmir, Turkey)
| |